NCT06782243Completed
Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome
Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome: Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 8 Jan 2026
Brief summary (registry, in English)
This study evaluates the effectiveness of high- and moderate-intensity statins in achieving target low-density lipoprotein cholesterol (LDL-C) levels in patients with acute coronary syndrome (ACS). The study aims to determine whether moderate-intensity statins can provide comparable benefits to high-intensity statins, particularly for patients at higher risk of adverse effects from higher doses. The findings may inform treatment decisions and reduce financial and clinical burdens on patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 190 (actual)
- First submitted
- 9 Jan 2025
- Start date
- 20 Dec 2024
- Primary completion date
- 30 Jul 2025
- Lead sponsor
- Khyber Medical University Peshawar
- Diseases
- Coronary artery disease
- NCT number
- NCT06782243
What you commit to
- Study type: Interventional
- Participants enrolled: 190
- From 20 Dec 2024 to the primary completion date, 30 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants already on statin therapy
Other illness
- History of adverse reactions to statins (e.g., hypersensitivity, myopathy, acute renal failure).
- Current acute liver disease.
Other
- Pregnant or breastfeeding women.
Who the study is looking for
- Participants aged between 25 and 85 years.
- Both males and females.
- Diagnosed with acute coronary syndrome as defined in the operational definitions.
Age in the registry: 25 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MTI-KTH (Medical Teaching Institution-Khyber Teaching Hospital), Peshawar-Pakistan Coordinator of this site? Confirm its status | Peshawar | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.